Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
T. Mellows (Southampton, United Kingdom). LSC - 2017 - Exosomal miRNA cargo in non small-cell lung cancer. 3296

Member's Comments

No comment yet.

Related content which might interest you: Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival Source: Eur Respir J 2011; 37: 617-623 Year: 2011 LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 XAGE-1b and p53: Potential targets for immunotherapy of non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 LSC - 2021 - Regulation of PA200 in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Lung cancer Source: Respipedia Article Year: 2018 Choice of endogenous control for gene expression in nonsmall cell lung cancer Source: Eur Respir J 2005; 26: 1002-1008 Year: 2005 Cyclooxygenase(COX)-2 is over-expressed in non small cell lung cancer (NSCLC) and is a potential target for treatment Source: Eur Respir J 2002; 20: Suppl. 38, 400s Year: 2002 Gene modules in non-small cell lung cancer Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 Small cell lung cancer in patients with elderly Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 24h-blood profile gene expression biomarkers of the response to bevacizumab-erlotinib (BE) in advanced non-squamous non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Fusion transcripts in lung cancer Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 LSC - 2021 - Macrophages in lung adenocarcinoma Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Pulmonary re-biopsy in non–small-cell lung cancer (NSCLC) locally advanced or metastatic  with EGFR-T790M resistance. Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound Year: 2018 LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 LSC - 2020 - Comprehensive characterization of the immune landscape within different molecular subtypes of small cell lung cancer (SCLC) Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Non-small cells lung cancer (NSCLC) in non-smokers (NS) – sharing experience Source: International Congress 2017 – Smoking and health hazards Year: 2017